HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lamifiban

a nonpeptide glycoprotein IIb/IIIa antagonist; prevents platelet loss during experimental cardiopulmonary bypass
Also Known As:
((1-(N-(p-(amidinobenzoyl)tyrosyl)-4-piperidinyl)oxy))acetic acid; Ro 44-9883; Ro 449883; Ro-44-9883
Networked: 26 relevant articles (4 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Harrington, Robert A: 2 articles (03/2005 - 12/2002)
2. Califf, Robert M: 2 articles (03/2005 - 12/2002)
3. Topol, Eric J: 2 articles (03/2005 - 12/2002)
4. Roe, Matthew T: 2 articles (03/2005 - 12/2002)
5. McBane, Robert D: 1 article (11/2013)
6. Wysokinski, Waldemar E: 1 article (11/2013)
7. Karnicki, Krzysztof: 1 article (11/2013)
8. Bayés, M: 1 article (01/2007)
9. Rabasseda, X: 1 article (01/2007)
10. Prous, J R: 1 article (01/2007)

Related Diseases

1. Acute Coronary Syndrome
2. Unstable Angina
3. Hemorrhage
4. Infarction
5. Neointima

Related Drugs and Biologics

1. Platelet Membrane Glycoprotein IIb
2. Heparin (Liquaemin)
3. eptifibatide (Integrilin)
4. tirofiban (Aggrastat)
5. paragon
6. Glycoproteins (Glycoprotein)
7. abciximab (ReoPro)
8. Aspirin (Acetylsalicylic Acid)
9. Creatinine
10. tenecteplase

Related Therapies and Procedures

1. Cardiopulmonary Bypass (Heart-Lung Bypass)
2. Stents
3. Angioplasty (Angioplasty, Transluminal)
4. Injections